Published in Life Sci on December 16, 1985
Alzheimer disease and platelets: how's that relevant. Immun Ageing (2012) 0.87
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun (2014) 0.82
Monoamine reuptake inhibitors in Parkinson's disease. Parkinsons Dis (2015) 0.78
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology (2005) 21.67
Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial. BMJ (1999) 5.36
Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci (1998) 4.76
Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47
Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology (1990) 4.41
Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet (1997) 4.39
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med (1995) 3.86
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. CMAJ (1999) 3.14
Pharmacotherapy of Alzheimer's disease: is there a need to redefine treatment success? Int J Geriatr Psychiatry (2001) 3.09
Safety and efficacy of galantamine in subjects with mild cognitive impairment. Neurology (2008) 2.79
A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease. Neurology (2001) 2.78
A proposal for the classification of sigma binding sites. Trends Pharmacol Sci (1992) 2.65
XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev (1998) 2.58
Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia. Am J Occup Ther (1999) 2.53
Circadian rhythms of melatonin and cortisol in aging. Biol Psychiatry (1989) 2.41
The effects of donepezil in Alzheimer's disease - results from a multinational trial. Dement Geriatr Cogn Disord (1999) 2.30
HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology (2010) 2.29
HSV-1 in brain and risk of Alzheimer's disease. Lancet (1998) 2.21
Management of Parkinson's disease a review of current and new therapies. Can J Neurol Sci (1999) 2.16
Relation between severity of Alzheimer's disease and costs of caring. CMAJ (1998) 2.12
The molecular pharmacology of CGRP and related peptide receptor subtypes. Trends Pharmacol Sci (2000) 2.04
The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1 Gly169 allele. Infect Immun (1996) 2.02
Neuroanatomical localization, pharmacological characterization and functions of CGRP, related peptides and their receptors. Neurosci Biobehav Rev (1997) 1.98
Basal cortisol levels and cognitive deficits in human aging. J Neurosci (1994) 1.97
Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease. Proc Natl Acad Sci U S A (1995) 1.91
Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry (2009) 1.86
Natural resistance to intracellular infections: Nramp1 encodes a membrane phosphoglycoprotein absent in macrophages from susceptible (Nramp1 D169) mouse strains. J Immunol (1996) 1.78
Health of family members caring for elderly persons with dementia. A longitudinal study. Ann Intern Med (1994) 1.67
Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65
Economic evaluation of donepezil in moderate to severe Alzheimer disease. Neurology (2004) 1.65
The effects of chronic antidepressant treatment in an animal model of anxiety. Psychopharmacology (Berl) (1988) 1.63
hCGRP8-37, a calcitonin gene-related peptide antagonist revealing calcitonin gene-related peptide receptor heterogeneity in brain and periphery. J Pharmacol Exp Ther (1990) 1.60
Androgen receptor antagonists (antiandrogens): structure-activity relationships. Curr Med Chem (2000) 1.59
The psychological and physical health of family members caring for an elderly person with dementia. J Clin Epidemiol (1992) 1.58
Stress-induced declarative memory impairment in healthy elderly subjects: relationship to cortisol reactivity. J Clin Endocrinol Metab (1997) 1.56
The Ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by beta-amyloid. Eur J Neurosci (2000) 1.56
Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity. Proc Natl Acad Sci U S A (1997) 1.55
The iron transport protein NRAMP2 is an integral membrane glycoprotein that colocalizes with transferrin in recycling endosomes. J Exp Med (1999) 1.53
Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci (1990) 1.51
Autoradiographic localization of angiotensin II receptors in rat brain. Proc Natl Acad Sci U S A (1984) 1.48
Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev Neurosci (1999) 1.47
Chemokines and chemokine receptors in the CNS: a possible role in neuroinflammation and patterning. Trends Pharmacol Sci (1999) 1.42
Structure-activity profile of calcitonin gene-related peptide in peripheral and brain tissues. Evidence for receptor multiplicity. J Pharmacol Exp Ther (1989) 1.42
Phencyclidine (angel dust)/sigma "opiate" receptor: visualization by tritium-sensitive film. Proc Natl Acad Sci U S A (1981) 1.39
Factors in the development of severe forms of tardive dyskinesia. Am J Psychiatry (1990) 1.39
Distinct electrophysiological properties of glutamatergic, cholinergic and GABAergic rat septohippocampal neurons: novel implications for hippocampal rhythmicity. J Physiol (2003) 1.39
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression. Proc Natl Acad Sci U S A (2000) 1.38
An analysis of the negative inotropic action of somatostatin. Br J Pharmacol (1979) 1.37
Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats. Neuroscience (1993) 1.34
Canadian Consensus Conference on Dementia: a physician's guide to using the recommendations. CMAJ (1999) 1.34
Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Prog Neurobiol (1992) 1.33
Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains. Proc Natl Acad Sci U S A (1995) 1.33
Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology (2001) 1.31
Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci (2001) 1.30
Insulin-like growth factor-1-induced phosphorylation of the forkhead family transcription factor FKHRL1 is mediated by Akt kinase in PC12 cells. J Biol Chem (2000) 1.29
Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases. J Neurochem (1992) 1.28
The recognition, assessment and management of dementing disorders: conclusions from the Canadian Consensus Conference on Dementia. Can J Neurol Sci (2001) 1.27
Folate deficiency and decreased brain 5-hydroxytryptamine synthesis in man and rat. Nature (1979) 1.26
Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice. Genomics (1998) 1.24
A comparison of the effects of diazepam versus several typical and atypical anti-depressant drugs in an animal model of anxiety. Psychopharmacology (Berl) (1989) 1.23
Morphine treatment induced calcitonin gene-related peptide and substance P increases in cultured dorsal root ganglion neurons. Neuroscience (2000) 1.21
Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol (1997) 1.20
Cell-specific and inducible Nramp1 gene expression in mouse macrophages in vitro and in vivo. J Leukoc Biol (1997) 1.20
Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol (2000) 1.20
Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience (2005) 1.20
Clinical effects of choline in Alzheimer's disease. Lancet (1978) 1.18
[3H]1,3-di(2-tolyl)guanidine and [3H](+)pentazocine binding sites in the rat brain: autoradiographic visualization of the putative sigma1 and sigma2 receptor subtypes. Neuroscience (1997) 1.17
Tryptophan, 5-hydroxyindoleacetic acid and indoleacetic acid in human cerebrospinal fluid: interrelationships and the influence of age, sex, epilepsy and anticonvulsant drugs. J Neurol Neurosurg Psychiatry (1980) 1.16
Standardization of the diagnosis of dementia in the Canadian Study of Health and Aging. Neuroepidemiology (1996) 1.15
Dehydroepiandrosterone (DHEA) protects hippocampal cells from oxidative stress-induced damage. Brain Res Mol Brain Res (1999) 1.13
Localization and modulation of calcitonin gene-related peptide-receptor component protein-immunoreactive cells in the rat central and peripheral nervous systems. Neuroscience (2003) 1.13
Blockade and reversal of spinal morphine tolerance by peptide and non-peptide calcitonin gene-related peptide receptor antagonists. Br J Pharmacol (2000) 1.12
Quantitative autoradiographic localization of [125I]insulin-like growth factor I, [125I]insulin-like growth factor II, and [125I]insulin receptor binding sites in developing and adult rat brain. J Comp Neurol (1993) 1.12
The Nramp2/DMT1 iron transporter is induced in the duodenum of microcytic anemia mk mice but is not properly targeted to the intestinal brush border. Blood (2000) 1.12
Acetylcholine release is elicited in the visual cortex, but not in the prefrontal cortex, by patterned visual stimulation: a dual in vivo microdialysis study with functional correlates in the rat brain. Neuroscience (2005) 1.11
Interleukin-2 as a neuroregulatory cytokine. Brain Res Brain Res Rev (1995) 1.10
Lewis and Fischer rats: a comparison of dopamine transporter and receptors levels. Brain Res (1998) 1.10
The disability assessment for dementia scale: a 12-month study of functional ability in mild to moderate severity Alzheimer disease. Alzheimer Dis Assoc Disord (2001) 1.10
The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia. Int Psychogeriatr (2010) 1.08
Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains. J Comp Neurol (1998) 1.08
The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. J Neurochem (2000) 1.08
BIIE0246, a potent and highly selective non-peptide neuropeptide Y Y(2) receptor antagonist. Br J Pharmacol (2000) 1.08
Amyloid beta-peptide inhibits high-affinity choline uptake and acetylcholine release in rat hippocampal slices. J Neurochem (1998) 1.08
A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia. J Neurosci (1996) 1.07
Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein. Brain Res (1993) 1.07
Comparative characterization and autoradiographic distribution of neuropeptide Y receptor subtypes in the rat brain. J Neurosci (1993) 1.07
Longitudinal study of basal cortisol levels in healthy elderly subjects: evidence for subgroups. Neurobiol Aging (1996) 1.07
C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle. Biol Reprod (1997) 1.06
Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group. Arch Neurol (1995) 1.06
Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol (1994) 1.06
Active site residues in m-calpain: identification by site-directed mutagenesis. FEBS Lett (1995) 1.06
Apoptosis in target organs of hypertension. Hypertension (1995) 1.05
A controlled dose-ranging study of remoxipride and haloperidol in schizophrenia--a Canadian multicentre trial. Acta Psychiatr Scand Suppl (1990) 1.05
Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa. N Engl J Med (1980) 1.05
First International Pharmacoeconomic Conference on Alzheimer's Disease: report and summary. Alzheimer Dis Assoc Disord (1998) 1.05
Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain. Peptides (1987) 1.05